Current and Upcoming Studies

Sort By:

Anti-Coronavirus (COVID-19) monoclonal antibody clinical trial for the prevention of COVID-19. It is not a vaccine.

Baptist Health Center for Clinical Research has been selected as one of the first two sites in the U.S. to study a novel COVID prevention agent, using two monoclonal antibodies instead of a vaccine. This new study will begin January 11.

View Trial Details
Ages 18+
Compensation* $875
Study Topics COVID prevention with monoclonal antibodies

*Compensation for time and travel may be available to those who qualify.

Coronavirus

View Trial Details
Ages 18+
Study Topics Coronavirus